Tag: KALV stock

Stock Earnings

KalVista Pharmaceuticals Inc [KALV] CHIEF DEVELOPMENT OFFICER makes an insider sale of 2,601 shares worth $25553.0.

KalVista Pharmaceuticals Inc’s recently made public that its CHIEF DEVELOPMENT OFFICER Yea Christopher unloaded Company’s shares for reported $25553.0 on

Analysts Viewpoint

KalVista Pharmaceuticals Inc [KALV] CHIEF DEVELOPMENT OFFICER makes an insider sale of 2,601 shares worth 25,553.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals

Insiders Updates

KALV Stock Sees Decline of Approximately -5.76% in Last Five Days

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or